Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Huge shorting today simple institutions own half the company they will be attacking tmrw huge gaps on upside
Only lesson here is set stop losses
Institutions are going to teach shorty a lesson! Stay tuned for some up side!
Weighted-average ordinary shares used to compute net loss per share attributable
to ordinary shareholders basic and diluted 143,175,224
https://d18rn0p25nwr6d.cloudfront.net/CIK-0001836056/32711112-e4d0-4538-9df1-baf19fa33d29.pdf
$AMAM:
there is no question this is headed to $5 as early as friday or next week.
float is just 14 million shares.
there is strong institutional ownership also.
nearly 50% of the stock is in institutional hands:
that says it all. only morons are selling.
nobody is smarter than those fund managers. they have done their DD before they decided to spend millions buying this stock.
and 50% institutional ownership is the strongest vote of confidence there is.
I have 100 percent confidence we are now heading up to 5 plus
it was well on its way when it hit $2.50.
then some group decided to flip it.
of course it is being shorted to death also.
but this news is too big:
they have a multi billion dollar drug:
and 100% disease control. it doesnt get any better than this:
The preliminary results showed a 51.7% overall response rate (ORR) and 100% disease control rate (DCR) following treatment with ARX788. Additionally, no drug-related serious adverse events (SAEs) were noted by any patients.
With investors reacting the way they did, it’s safe to say they were impressed with the results; considering how big the breast cancer market is, the drug’s potential has caused a bit of a stir.
$AMAM:
lets see a green close today.
i still think we will see $3 today.
either later before the close or in after hours trading.
-----------------------------------------------------------
again this news is simply too damn big.
The preliminary results showed a 51.7% overall response rate (ORR) and 100% disease control rate (DCR) following treatment with ARX788. Additionally, no drug-related serious adverse events (SAEs) were noted by any patients.
With investors reacting the way they did, it’s safe to say they were impressed with the results; considering how big the breast cancer market is, the drug’s potential has caused a bit of a stir.
https://stockcharts.com/h-sc/ui?s=amam&p=D&yr=0&mn=6&dy=0&id=p38090673899
https://www.barchart.com/stocks/quotes/amam/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=CGRA&grid=1&height=210&studyheight=100
https://www.barchart.com/stocks/quotes/amam/opinion
Open gap at .50 may need to fill!
$AMAM:
potentially a multi billion dollar drug here folks:
we are probably looking at a $50 to $70 dollar stock in time here.
The preliminary results showed a 51.7% overall response rate (ORR) and 100% disease control rate (DCR) following treatment with ARX788. Additionally, no drug-related serious adverse events (SAEs) were noted by any patients.
With investors reacting the way they did, it’s safe to say they were impressed with the results; considering how big the breast cancer market is, the drug’s potential has caused a bit of a stir.
$AMAM:
this is too cheap given these results:
market is massive:
The preliminary results showed a 51.7% overall response rate (ORR) and 100% disease control rate (DCR) following treatment with ARX788. Additionally, no drug-related serious adverse events (SAEs) were noted by any patients.
With investors reacting the way they did, it’s safe to say they were impressed with the results; considering how big the breast cancer market is, the drug’s potential has caused a bit of a stir.
Idk yet might want lower
$AMAM:
i think this is the bottom.
it should start climbing now.
i added a few more also.
looking for $3 here today or in after hours trading.
$AMAM:
$3 close quite possible here.
this is a good dip buy opportunity.
i grabbed a few more.
Two Phase 3 studies and one registration enabled Phase 2 study with ARX788 (ACE-Breast-02, ACE-Gastric-02, and ACE-Breast-08) conducted by Amrbrx’s partner, NovoCodex Biopharmaceuticals, are ongoing in China with projected readouts in 2023.
I'm in here for 10k holding for at least 5>7 plus
Load and hold folks.
This is at $10 next week if not this week.
This is going green today.
Agreed. But I think a lot sooner than a year
$AMAM:
100% disease control is simply massive.
we are looking at a $50 dollar stock here.
1 year price target is $50 to $60.
57% success rates during trial phase is huge! This is potentially the official cure for breast cancer. Thought I’d never see this in my lifetime. Truly incredible. This stock should be $100+. Curing breast cancer is priceless. Cheers to all that held their shares!
and 100% disease control rate (DCR) !!!!!!!!!!! huge
AMAM:Just noticed AMAM is on IHUB now.Great news last Friday for those who saw it early
Monday we fly! Multiple successful trials, this is potentially the cure for breast cancer! Only shorts coming in here are retail shorts, HF shorts won’t touch this, we watched them all get roasted Friday, one short posted on Twitter he lost $30k Friday trying to short this! Burning shorts is a huge win and I couldn’t be happier!
Looks like your about to blow your entire short position. Don’t be this guy that tried shorting AMAM Friday and lost $30k..
Not fun to post this one.... $AMAM destroyed me. Huge size, halted up twice couldn't get out. Not all fun and games sports fans. Back at it Monday. Went from +$30k to -$10k on the month. Luckily, I can handle that. 💀 pic.twitter.com/EMhjH8oy57
— Drysdale (@traderdrysdale) December 9, 2022
Agreed, this is potentially the cure for breast cancer. We could just see a massive parabolic move next week to $100 if we get any more news. This is $HKD 2.0 loaded and holding
6500 shares
6500 dollars?
Someone said that they were making a presentation after hours anyone know if that is correct or have the details?
Loaded 6500 before close , hoping for big jump, who cares if dips, drug is very promising, will above $10 easy
We may see More news next week.
Sell time just passed
Loaded 6500 before close , hoping for big jump, who cares if dips, drug is very promising, will above $10 easy
Tragte $10 easy , this can go much higher based on drug data.FDA can rush for Phase III Open level, drug is great, no toxicity found, they can treat millions of people .
AVentis or Astra may swallow them or make a deal with them
Yeah...but what's happened since then? Dilution? Or just savage shorting?
Let's rub off on my investments!! Thanks in advance!! Lol!!
$AMAM: Many thanks........ pretty good day here, right
Closed here at 4.53........... started the day at 0.45
Not to shabby.
Now we watch $TMNA go from 0.70 to min target of $7
GO $AMAM
All this over Phase 2 results showing 57% effectiveness? This run up can't be just for the study results. This thing must have been shorted to dirt.
Congratulation on the profit last week. I traded TOPS instead of the 10,000% runner.
Followers
|
7
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
125
|
Created
|
12/09/22
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |